Compare · OPCH vs TOI
OPCH vs TOI
Side-by-side comparison of Option Care Health Inc. (OPCH) and The Oncology Institute Inc. (TOI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both OPCH and TOI operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- OPCH is the larger of the two at $3.41B, about 6.4x TOI ($534.9M).
- TOI has been more active in the news (8 items in the past 4 weeks vs 4 for OPCH).
- OPCH has more recent analyst coverage (16 ratings vs 8 for TOI).
- Company
- Option Care Health Inc.
- The Oncology Institute Inc.
- Price
- -
- -
- Market cap
- $3.41B
- $534.9M
- 1M return
- -
- +4.79%
- 1Y return
- -
- +53.00%
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2020
- News (4w)
- 4
- 8
- Recent ratings
- 16
- 8
Option Care Health Inc.
Option Care Health, Inc. offers home and alternate site infusion services in the United States. The company provides immunoglobulin infusion therapies for the treatment of immune deficiencies; anti-infective therapies and services; home infusion services to treat heart failures; and treatments for chronic inflammatory disorders, including Crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders; and immunoglobulin infusion therapies. It also offers infusion therapies for bleeding disorders; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; and other infusion therapies to treat various conditions, including pain management, chemotherapy, and respiratory medications. In addition, the company offers therapies that women need to survive and thrive through high-risk pregnancies; treatments to manage the progression of neurological disorders, such as amyotrophic lateral sclerosis and duchenne muscular dystrophy; and nursing services. The company is headquartered in Bannockburn, Illinois.
The Oncology Institute Inc.
The Oncology Institute, Inc. provides cancer awareness, prevention, diagnosis, treatment, and education service. The company offers chemotherapy education, comprehensive lab testing, pain management, financial counseling, end of life counseling, dietary counseling, in-house infusion center, in-house support groups, in-house pharmacy, nutraceuticals, clinical trials, and educational seminars. It also operates the hope, health, and healing center to offer patients alternative and holistic treatments in addition to chemotherapy. The Oncology Institute, Inc. was founded in 2007 and is based in Cerritos, California.
Latest OPCH
- Option Care Health downgraded by Stephens with a new price target
- Option Care Health to Announce Second Quarter 2026 Financial Results and Host Conference Call
- EVP Sp Sales & Solutions Bhatia Prateek was granted 39,795 shares (SEC Form 4)
- SEC Form 3 filed by new insider Bhatia Prateek
- Goldman initiated coverage on Option Care Health with a new price target
- Option Care Health Appoints Robert Okunski as Vice President, Investor Relations
- Option Care Health Awarded TIME's World's Most Impactful Companies 2026 Ranking
- Director Bierbower Elizabeth D was granted 8,997 shares, increasing direct ownership by 38% to 32,871 units (SEC Form 4)
- Director Deckmann Natasha was granted 9,841 shares, increasing direct ownership by 44% to 32,002 units (SEC Form 4)
- Director Kraemer Harry M Jansen Jr was granted 21,076 shares, increasing direct ownership by 5% to 471,076 units (SEC Form 4)
Latest TOI
- Chief Medical Officer Podnos Yale exercised 23,452 shares at a strike of $1.90 and sold $150,340 worth of shares (23,452 units at $6.41) (SEC Form 4)
- Large owner Chernett Jorey bought $87,750 worth of shares (15,000 units at $5.85), increasing direct ownership by 0.14% to 10,630,858 units (SEC Form 4)
- Director Tzoumakas Kimberly Jo was granted 17,185 shares (SEC Form 4)
- Director Stolper Mark was granted 25,833 shares (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits
- The Oncology Institute Completes Strategic Refinancing with OrbiMed, Repaying the Outstanding $86 Million Deerfield Convertible Note, Strengthening its Balance Sheet, and Improving Liquidity
- Lake Street initiated coverage on The Oncology Institute with a new price target
- Large owner Chernett Jorey bought $90,360 worth of shares (18,000 units at $5.02), increasing direct ownership by 0.17% to 10,615,858 units (SEC Form 4)
- The Oncology Institute Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders
- Chief Medical Officer Podnos Yale sold $126,094 worth of shares (23,451 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 259,527 units (SEC Form 4)